cjc-1295 + ipamorelin: Ipamorelin Blend Canada CJC‑1295 & Ipamorelin Therapy |

Consult a dermatologist for persistent acne or scarring

After the 26-week treatment period, the mean percentage of weight reduction from baseline was greater with all doses of cagrilintide (0.34.5 mg, 6.0%10.8%) versus placebo (3.0%)

Specifications Content: Dihexa (lyophilised) Form: Freeze-dried powder Purity: 98% (HPLC-verified) COA: Certificate of Analysis provided with each batch Storage: 20C prior to dispatch Intended Use: Laboratory research only This product is intended strictly for laboratory research purposes and is not approved for human consumption, animal use, therapeutic applications, or diagnostic procedures.

Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K